Cargando…

Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: Previously reported results have shown promising efficacy of neoadjuvant immunotherapy for resectable non–small cell lung cancer (NSCLC). However, no randomized control trials comparing neoadjuvant immunotherapy with chemotherapy have yet been reported. The aim of the present study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Hong, Hui-Zhao, Wu, Yi-Long, Zhong, Wen-Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Thoracic: Lung Cancer: Expert Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390514/ https://www.ncbi.nlm.nih.gov/pubmed/36004199 http://dx.doi.org/10.1016/j.xjon.2021.08.036

Ejemplares similares

Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis
por: Harling, Leanne, et al.
Publicado: (2020)

Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023)

A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)
por: Kunitoh, Hideo, et al.
Publicado: (2020)

Eurolung risk score is associated with long-term survival after curative resection for lung cancer
por: Brunelli, Alessandro, et al.
Publicado: (2021)

Visualization of patterns of lymph node metastases in non–small cell lung cancer using network analysis
por: Yoshida, Yukihiro, et al.
Publicado: (2022)

Asia expert consensus on segmentectomy in non–small cell lung cancer: A modified Delphi study
por: Liu, Lunxu, et al.
Publicado: (2023)

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
por: Tang, Andrew, et al.
Publicado: (2022)

Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023)

Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022)

Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer
por: Krantz, Seth B., et al.
Publicado: (2022)

Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity
por: Feldman, Hope A., et al.
Publicado: (2022)

Feasibility study of a novel wireless localization technique using radiofrequency identification markers for small and deeply located lung lesions
por: Yutaka, Yojiro, et al.
Publicado: (2022)

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study
por: Takenaka, Tomoyoshi, et al.
Publicado: (2022)

Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022)

Treatment quality and outcomes vary with hospital burden of uninsured and Medicaid patients with cancer in early non–small cell lung cancer
por: Muslim, Zaid, et al.
Publicado: (2022)

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022)

PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
por: Meng, Xiangjiao, et al.
Publicado: (2022)

Surgical markup in lung cancer resection, 2015-2020
por: Robinson, Eric, et al.
Publicado: (2023)

Evaluation of deployment capability of a novel outside-the-scope, detachable catheter system for ablation of lung lesions in ex vivo human lung models
por: Huseini, Taha, et al.
Publicado: (2022)

Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy
por: Kagimoto, Atsushi, et al.
Publicado: (2020)

Outcome following unplanned critical care admission after lung resection
por: Shelley, Ben, et al.
Publicado: (2022)

Safety of lung cancer surgery during COVID-19 in a pandemic epicenter
por: Villena-Vargas, Jonathan, et al.
Publicado: (2022)

Nonintubated versus intubated “one-stage” preoperative localization and thoracoscopic lung resection
por: Hsu, Po-Kuei, et al.
Publicado: (2021)

New or enlarging hiatal hernias after thoracic surgery for early lung cancer
por: Song, Kimberly J., et al.
Publicado: (2022)

Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer
por: Bao, Yi, et al.
Publicado: (2022)

Impact of robotic access on outcomes after lung cancer surgery in France: Analysis from the Epithor database
por: Madelaine, Leslie, et al.
Publicado: (2023)

Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness
por: Mimae, Takahiro, et al.
Publicado: (2022)

The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction
por: Mimae, Takahiro, et al.
Publicado: (2022)

Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: An instrumental variable analysis
por: Littau, Michael J., et al.
Publicado: (2022)

Trends of utilization and perioperative outcomes of robotic and video-assisted thoracoscopic surgery in patients with lung cancer undergoing minimally invasive resection in the United States
por: Alwatari, Yahya, et al.
Publicado: (2022)

Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy
por: Ishii, Hidenobu, et al.
Publicado: (2017)

A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
por: Liu, Yutao, et al.
Publicado: (2020)

Left secondary carinal resection and reconstruction for low-grade bronchial malignancies
por: Chen, Liang, et al.
Publicado: (2021)

The learning curve of video-assisted thoracoscopic sleeve lobectomy in a high-volume pulmonary center
por: Deng, Jiajun, et al.
Publicado: (2021)

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS(G12C)-Mutant Non-Small Cell Lung Cancer
por: Elkrief, Arielle, et al.
Publicado: (2023)

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
por: Marrone, Kristen A., et al.
Publicado: (2018)

Uniportal Versus Multiportal Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: An Updated Meta-analysis
por: Magouliotis, Dimitrios E., et al.
Publicado: (2021)

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
por: Hsu, Melinda L, et al.
Publicado: (2022)

Minimally invasive lung resection after induction therapy: Is there evidence?
por: Park, Bernard J.
Publicado: (2021)

Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis
por: Wang, Chunsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e1gai3l8c8ek3nc7pu17c8kg8